Usefulness of Preoperative Oral Glucose Tolerance Testing for Perioperative Risk Stratification in Patients Scheduled for Elective Vascular Surgery

American Journal of Cardiology

Volumn 101, Issue 4, 2008, Pages 526-529

  Dunkelgrun, Martin ^a   Schreiner, Frodo ^a   Schockman, David B ^a   Hoeks, Sanne E ^a   Feringa, Harm H H ^a   Goei, Dustin ^a   Schouten, Olaf ^a   Welten, Gijs M J M ^a   Vidakovic, Radosav ^a   Noordzij, Peter G ^a   Boersma, Eric ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TROPONIN;

AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; ELECTIVE SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN SECRETION; RISK ASSESSMENT; ST SEGMENT; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; VASCULAR SURGERY;

AGE FACTORS; AGED; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HEART FAILURE; HUMANS; KIDNEY FAILURE; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; VASCULAR SURGICAL PROCEDURES;

EID: 38849120777     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.103     Document Type: Article

References (12)

1. Boersma E., Kertai M.D., Schouten O., Bax J.J., Noordzij P., Steyerberg E.W., Schinkel A.F., van Santen M., Simoons M.L., Thomson I.R., et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118 (2005) 1134-1141
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 30 suppl (2007) S42-S47
3. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., Hiratzka L.F., Murphy W.R., Olin J.W., Puschett J.B., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006) e463-e654
4. Lankisch M., Füth R., Schotes D., Rose B., Lapp H., Rathmann W., Haastert B., Gülker H., Scherbaum W.A., and Martin S. High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol 95 (2006) 80-87
5. Greberski K., Guzik P., and Wysocki R. Prospective evaluation of glucose metabolism in patients undergoing coronary artery bypass grafting. Kardiol Pol 64 (2006) 1187-1193
6. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
7. DECODE Study Group, the European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
8. Hanefeld M., Temelkova-Kurktschiev T., Schaper F., Henkel E., Siegert G., and Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16 (1999) 212-218
9. Rathmann W., Giani G., and Mielck A. Cardiovascular risk factors in newly diagnosed abnormal glucose tolerance: comparison of 1997 ADA and 1985 WHO criteria. Diabetologia 42 (1999) 1268-1269
10. Edelstein S.L., Knowler W.C., Bain R.P., Andres R., Barrett-Connor E.L., Dowse G.K., Haffner S.M., Pettitt D.J., Sorkin J.D., Muller D.C., et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46 (1997) 701-710
11. de Vegt F., Dekker J.M., Stehouwer C.D., Nijpels G., Bouter L.M., and Heine R.J. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 21 (1998) 1686-1690
12. Buse J.B., Ginsberg H.N., Bakris G.L., Clark N.G., Costa F., Eckel R., Fonseca V., Gerstein H.C., Grundy S., Nesto R.W., et al., American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 115 (2007) 114-126